Tendai Kadiyirire

Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa

Ellie Rashidghamat, Tendai Kadiyirire, Salma Ayis et al. · Journal of the American Academy of Dermatology · 2019 · 112 citations · Full text

Medicine, Clinical Sciences, Dermatology +14

Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa

Su M. Lwin, Farhatullah Syed, Wei‐Li Di et al. · JCI Insight · 2019 · 90 citations · Full text

Medicine, Dermatology, Pathology +14

Generation and Clinical Application of Gene-Modified Autologous Epidermal Sheets in Netherton Syndrome: Lessons Learned from a Phase 1 Trial

Wei‐Li Di, Su M. Lwin, Anastasia Petrova et al. · Human Gene Therapy · 2019 · 39 citations · Full text

Life Sciences, Dermatology, Genetics +14